港股異動丨港交所(0388.HK)漲2.33% 行政總裁人選落定
格隆匯2月10日丨港交所(0388.HK)漲2.33%,報526.5港元,總市值6675億港元。港交所昨日收市後宣佈委任歐冠昇先生由2021年5月24日起出任香港交易所集團行政總裁,為期三年至2024年5月23日止,有關委任待取得證券及期貨事務監察委員會根據《證券及期貨條例》第70條批准後才生效。待取得該批准後,歐冠昇先生亦將出任董事會的當然成員,於2021年5月24日生效。歐冠昇成為港交所自2000年合併及上市以來第四任,以及首位非華裔行政總裁。港交所前任CEO李小加回應查詢時稱,歐冠昇是“我的一位好朋友,也是中國的好朋友,香港的好朋友”,相信他將成為一位優秀的行政總裁。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.